[1]
J. Claude Tardiff, G. P Curnew, J. Marie Leclerc, and B. Réhel, “REACHING THE THERAPEUTIC GOAL IN HYPERTENSION: RESULTS FROM THE CANADIAN VALSARTAN OBSERVATIONAL STUDY (DIOVANTAGE 4)”, J Popl Ther Clin Pharmacol, vol. 15, no. 2, Dec. 2018, Accessed: Oct. 10, 2025. [Online]. Available: https://www.jptcp.com/index.php/jptcp/article/view/218